Fred Alger Management’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Buy |
1,618,649
+708,040
| +78% | +$9.15M | 0.09% | 117 |
|
|
2025
Q1 | $7.07M | Sell |
910,609
-223,335
| -20% | -$1.73M | 0.04% | 192 |
|
|
2024
Q4 | $25.8M | Buy |
1,133,944
+1,051,246
| +1,271% | +$23.9M | 0.12% | 111 |
|
|
2024
Q3 | $462K | Buy |
82,698
+9,139
| +12% | +$51.1K | ﹤0.01% | 381 |
|
|
2024
Q2 | $988K | Hold |
73,559
| – | – | ﹤0.01% | 358 |
|
|
2024
Q1 | $1.28M | Hold |
73,559
| – | – | 0.01% | 363 |
|
|
2023
Q4 | $1.51M | Hold |
73,559
| – | – | 0.01% | 348 |
|
|
2023
Q3 | $1.22M | Buy |
+73,559
| New | +$1.22M | 0.01% | 352 |
|
|
2021
Q3 | – | Sell |
-48,701
| Closed | -$40.9M | – | 531 |
|
|
2021
Q2 | $40.9M | Buy |
48,701
+26,417
| +119% | +$22.2M | 0.1% | 172 |
|
|
2021
Q1 | $19.1M | Buy |
22,284
+2,963
| +15% | +$2.54M | 0.05% | 206 |
|
|
2020
Q4 | $17.6M | Buy |
19,321
+688
| +4% | +$626K | 0.05% | 202 |
|
|
2020
Q3 | $22.6M | Sell |
18,633
-10,333
| -36% | -$12.5M | 0.07% | 159 |
|
|
2020
Q2 | $10.6M | Buy |
+28,966
| New | +$10.6M | 0.03% | 184 |
|